Hiroyuki Sasaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroyuki Sasaki has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Takeshi Matsui
Tokyo University of Technology
3 shared publications Emi Kikuchi
Core Research Facilities, School of Medicine, The Jikei University
2 shared publicationsHideki Saito
Core Research Facilities, School of Medicine, The Jikei University
2 shared publications- Masayuki Amagai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
2 shared publications - Aiko Shiohama
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; KOSÉ Endowed Program for Skin Care and Allergy Prevention, Keio University School of Medicine, Tokyo, Japan
1 shared publication - Akatsuki Saito
Department of Veterinary Medicine, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan
1 shared publication
Latest Publications
- Open Access
- 3 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (36)
Lenacapavir binding to immature Gag induces giant virions and causes protease-dependent inhibition of viral release
Lenacapavir (LEN), a potent capsid inhibitor, suppresses reverse transcription and nuclear import by disrupting capsid core formation in HIV type 1 (HIV-1). However, its effects on late-stage viral assembly remain unclear. Although p24 ELISA suggested that LEN substantially inhibited HIV-1, both RT-dPCR and Vpr-HiBiT assays indicated that suppression of viral release required relatively high LEN concentrations. This discrepancy was attributed to LEN-induced reduction in p24 solubility, leading to an overestimation of its inhibitory effect on viral release. In addition, excessive intracellular Gag processing by the viral protease was observed in the presence of LEN, which contributed to impaired viral release. Furthermore, LEN induced numerous abnormal, discrete clusters of Gag at the plasma membrane. Using mass photometry, which was applied to analyze HIV-1 particle sizes, and transmission electron microscopy, we identified heterogeneous LEN-induced viral-like particles (LENiVLPs; diameter >200 nm) containing both Gag and Env proteins. Although LENiVLPs retained membrane fusion capability, they were noninfectious owing to postentry defects that prevented viral replication. Thus, LEN binds to the precursor Gag and promotes aberrant particle formation, offering insights that could guide the development of next-generation LEN-based therapeutics targeting the late stages of the viral life cycle.
- 3 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (36)
Open AccessLenacapavir binding to immature Gag induces giant virions and causes protease-dependent inhibition of viral release
Lenacapavir (LEN), a potent capsid inhibitor, suppresses reverse transcription and nuclear import by disrupting capsid core formation in HIV type 1 (HIV-1). However, its effects on late-stage viral assembly remain unclear. Although p24 ELISA suggested that LEN substantially inhibited HIV-1, both RT-dPCR and Vpr-HiBiT assays indicated that suppression of viral release required relatively high LEN concentrations. This discrepancy was attributed to LEN-induced reduction in p24 solubility, leading to an overestimation of its inhibitory effect on viral release. In addition, excessive intracellular Gag processing by the viral protease was observed in the presence of LEN, which contributed to impaired viral release. Furthermore, LEN induced numerous abnormal, discrete clusters of Gag at the plasma membrane. Using mass photometry, which was applied to analyze HIV-1 particle sizes, and transmission electron microscopy, we identified heterogeneous LEN-induced viral-like particles (LENiVLPs; diameter >200 nm) containing both Gag and Env proteins. Although LENiVLPs retained membrane fusion capability, they were noninfectious owing to postentry defects that prevented viral replication. Thus, LEN binds to the precursor Gag and promotes aberrant particle formation, offering insights that could guide the development of next-generation LEN-based therapeutics targeting the late stages of the viral life cycle.
- Open Access
- 6 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0318556
Development of a novel evaluation method by mathematical anatomy for foot bone alignment displacement using x-ray radiographs
The major methods of evaluating the foot arch in clinical practice in patients with foot deformities are medial longitudinal arch measurement using body surface somatometry and radiographic morphometry. Although these methods are widely used, they are considered problematic in terms of differences in scores between the methods. In this study, we developed a new geometric shape analysis method for the bony arrangement of the foot using the two-dimensional fast Fourier transform (2D-FFT), which incorporates mathematical anatomy using x-ray radiographs. Lateral radiographs of the foot bones were obtained using ImageJ2 provided by the National Institutes of Health. The 2D-FFT images show the characteristic directional power spectrum extending from low to high frequencies in the first and third quadrants on the normal, low and high arched foot respectively. The current method of reflecting the bone arrangement status of the metatarsal and tarsal bones may have the potential to establish a new radiographic evaluation method for assessing abnormal foot–bone alignment. As a result, the foot bone 2D-FFT method can be useful in assessing the medial longitudinal arch and predicting the prognosis of these patients.
- 6 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0318556
Open AccessDevelopment of a novel evaluation method by mathematical anatomy for foot bone alignment displacement using x-ray radiographs
The major methods of evaluating the foot arch in clinical practice in patients with foot deformities are medial longitudinal arch measurement using body surface somatometry and radiographic morphometry. Although these methods are widely used, they are considered problematic in terms of differences in scores between the methods. In this study, we developed a new geometric shape analysis method for the bony arrangement of the foot using the two-dimensional fast Fourier transform (2D-FFT), which incorporates mathematical anatomy using x-ray radiographs. Lateral radiographs of the foot bones were obtained using ImageJ2 provided by the National Institutes of Health. The 2D-FFT images show the characteristic directional power spectrum extending from low to high frequencies in the first and third quadrants on the normal, low and high arched foot respectively. The current method of reflecting the bone arrangement status of the metatarsal and tarsal bones may have the potential to establish a new radiographic evaluation method for assessing abnormal foot–bone alignment. As a result, the foot bone 2D-FFT method can be useful in assessing the medial longitudinal arch and predicting the prognosis of these patients.
- 23 June 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (11) , 2864-2872.e6
Microbiota-Independent Spontaneous Dermatitis Associated with Increased Sebaceous Lipid Production in Tmem79-Deficient Mice
- 23 June 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (11) , 2864-2872.e6
Microbiota-Independent Spontaneous Dermatitis Associated with Increased Sebaceous Lipid Production in Tmem79-Deficient Mice
- Open Access
- 17 June 2022
- Published by Springer Nature in Research Square
Electron microscopic double staining method with hematoxylin followed by lead citrate
In this study, a new staining method for electron microscopic specimens is used. The method is based on the double staining of hematoxylin, which is widely used as a staining agent for light microscopy, with lead solution, and is expected to replace the conventional double staining method of uranyl acetate and lead solution in terms of safety, cost, and ease of handling.
- 17 June 2022
- Published by Springer Nature in Research Square
Open AccessElectron microscopic double staining method with hematoxylin followed by lead citrate
In this study, a new staining method for electron microscopic specimens is used. The method is based on the double staining of hematoxylin, which is widely used as a staining agent for light microscopy, with lead solution, and is expected to replace the conventional double staining method of uranyl acetate and lead solution in terms of safety, cost, and ease of handling.
- Open Access
- 16 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-7
Novel electron microscopic staining method using traditional dye, hematoxylin
Uranyl acetate (UA) has been routinely used as a staining solution for ultrathin sections used in biological electron microscopy. As a radioactive nuclear material, UA is subject to strict international regulations. To develop an alternative and easy-to-use staining method for ultrathin sections, we examined various commercial light microscopic dyes. We found that Mayer’s hematoxylin followed by Reynold’s lead citrate solution showed staining results comparable to UA and Reynold’s lead citrate solution, and this method is therefore suggested as a reliable and promising alternative to UA staining.
- 16 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-7
Open AccessNovel electron microscopic staining method using traditional dye, hematoxylin
Uranyl acetate (UA) has been routinely used as a staining solution for ultrathin sections used in biological electron microscopy. As a radioactive nuclear material, UA is subject to strict international regulations. To develop an alternative and easy-to-use staining method for ultrathin sections, we examined various commercial light microscopic dyes. We found that Mayer’s hematoxylin followed by Reynold’s lead citrate solution showed staining results comparable to UA and Reynold’s lead citrate solution, and this method is therefore suggested as a reliable and promising alternative to UA staining.
- Open Access
- 14 December 2009
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 187 (6) , i14
External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers
- 14 December 2009
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 187 (6) , i14
Open AccessExternal antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers
- Open Access
- 1 January 1998
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 60 (6) , 699-704
Functional Relationship between Muscles of Mastication and the Skull with Enlarged Orbit in the Baikal Seal (Phoca sibirica).
We expected that the enlarged area of zygomatic arch, one of some skull characters adapted for enlarged eye, has an influence on form and function of muscles of mastication in the Baikal seal (Phoca sibirica). So, in this species, the Mm. masseter, temporalis, pterygoidei, digastricus were observed in the macroscopic level. The skull characters related to these muscles were also compared between the Baikal seal and a close-related species, the ringed seal (Phoca hispida). The Mm. masseter and temporalis were well-developed using the enlarged attachment area of zygomatic arch. In contrast, the M. digastricus is suggested to be not so important in the Baikal seal, because the temporal bone is not so developed as in the ringed seal. It is suggested that the Baikal seal has especially developed the Mm. temporalis and masseter using an enlarged area of zygomatic arch among Pusa species. We also suggest that the robust temporal bone is equipped to have the M. digastricus developed as a main retractor of mandibular body in the ringed seal.
- 1 January 1998
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 60 (6) , 699-704
Open AccessFunctional Relationship between Muscles of Mastication and the Skull with Enlarged Orbit in the Baikal Seal (Phoca sibirica).
We expected that the enlarged area of zygomatic arch, one of some skull characters adapted for enlarged eye, has an influence on form and function of muscles of mastication in the Baikal seal (Phoca sibirica). So, in this species, the Mm. masseter, temporalis, pterygoidei, digastricus were observed in the macroscopic level. The skull characters related to these muscles were also compared between the Baikal seal and a close-related species, the ringed seal (Phoca hispida). The Mm. masseter and temporalis were well-developed using the enlarged attachment area of zygomatic arch. In contrast, the M. digastricus is suggested to be not so important in the Baikal seal, because the temporal bone is not so developed as in the ringed seal. It is suggested that the Baikal seal has especially developed the Mm. temporalis and masseter using an enlarged area of zygomatic arch among Pusa species. We also suggest that the robust temporal bone is equipped to have the M. digastricus developed as a main retractor of mandibular body in the ringed seal.
- 1 July 1993
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 9 (7) , 619-626
Complement-Dependent Virolysis of HIV-1 with Monoclonal Antibody NM-01
Previous studies have described the isolation of monoclonal antibodies that neutralize human immunodeficiency virus type 1 (HIV-1). However, although certain antibodies are capable of blocking infection of CD4 + cells, the antibody-HIV-1 complex could potentially remain infectious and enter cells by an Fc receptor-mediated mechanism. Indeed, one goal of HIV-1 therapy with antibodies is the development of reagents capable of killing virus. The present studies with murine monoclonal antibody (MoAb) NM-01 demonstrate complement-mediated lysis of HIV-1. NM-01-dependent virolysis has been visualized by electron microscopy. Virus particles treated with NM-01 and rabbit or human complement undergo a process of outer envelope rupture and loss of the electron-dense core. The involvement of human complement in this process was confirmed by the presence of C9 in association with MoAb NM-01 immune complexes. In contrast, virolysis was not detectable with antibody or complement alone. Moreover, although MoAb NM-01 alone is capable of neutralizing HIV-1, the presence of rabbit complement was associated with over a 10-fold decrease in infectivity. Similar but less pronounced effects were observed with human complement. These findings support a potential role for antibody-dependent complement-mediated virolysis in HIV-1 therapy.
- 1 July 1993
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 9 (7) , 619-626
Complement-Dependent Virolysis of HIV-1 with Monoclonal Antibody NM-01
Previous studies have described the isolation of monoclonal antibodies that neutralize human immunodeficiency virus type 1 (HIV-1). However, although certain antibodies are capable of blocking infection of CD4 + cells, the antibody-HIV-1 complex could potentially remain infectious and enter cells by an Fc receptor-mediated mechanism. Indeed, one goal of HIV-1 therapy with antibodies is the development of reagents capable of killing virus. The present studies with murine monoclonal antibody (MoAb) NM-01 demonstrate complement-mediated lysis of HIV-1. NM-01-dependent virolysis has been visualized by electron microscopy. Virus particles treated with NM-01 and rabbit or human complement undergo a process of outer envelope rupture and loss of the electron-dense core. The involvement of human complement in this process was confirmed by the presence of C9 in association with MoAb NM-01 immune complexes. In contrast, virolysis was not detectable with antibody or complement alone. Moreover, although MoAb NM-01 alone is capable of neutralizing HIV-1, the presence of rabbit complement was associated with over a 10-fold decrease in infectivity. Similar but less pronounced effects were observed with human complement. These findings support a potential role for antibody-dependent complement-mediated virolysis in HIV-1 therapy.